Jale Moradi
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Tuberculosis Research and Epidemiology 4
- SARS-CoV-2 and COVID-19 Research 3
- Clostridium difficile and Clostridium perfringens research 2
-
- vaccines and immunoinformatics approaches 6
- Gut microbiota and health 3
- Co-authors
- Farhad B. Hashemi (1 shared paper)Abbas Bahador (1 shared paper)Ramin Abiri (11 shared papers)Esmaeil Babaei (1 shared paper)Mohammad M. Feizabadi (1 shared paper)Mehri Haeili (1 shared paper)Hamid Motamedi (6 shared papers)Marzie Mahdizade Ari (2 shared papers)
- Journals
- Osong Public Health and Research Perspectives (2 papers)Scientific Reports (1 paper)BMC Bioinformatics (1 paper)Sensing and Bio-Sensing Research (1 paper)International Immunopharmacology (1 paper)
- Partner nations
- IranGermanyUnited Kingdom
In The Last Decade
Jale Moradi
20 papers receiving 291 citations
Peers
Comparison fields: 5 of 61
- Molecular Medicine 146
- Applied Microbiology and Biotechnology 21
- Endocrinology 52
- Pollution 59
- Infectious Diseases 76
Countries citing papers authored by Jale Moradi
This map shows the geographic impact of Jale Moradi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jale Moradi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jale Moradi more than expected).
Fields of papers citing papers by Jale Moradi
This network shows the impact of papers produced by Jale Moradi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jale Moradi. The network helps show where Jale Moradi may publish in the future.
Co-authors
The 25 scholars most cited alongside Jale Moradi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 76 | |
| 2 | 2015 | 71 | |
| 3 | 2021 | 35 | |
| 4 | 2023 | 20 | |
| 5 | 2021 | 16 | |
| 6 | 2017 | 12 | |
| 7 | 2013 | 12 | |
| 8 | 2022 | 9 | |
| 9 | 2023 | 8 | |
| 10 | 2023 | 8 | |
| 11 | 2014 | 7 | |
| 12 | 2023 | 4 | |
| 13 | 2022 | 3 | |
| 14 | 2025 | 3 | |
| 15 | 2022 | 3 | |
| 16 | An evaluation study on phenotypical methods and real-time PCR for detection of Mycobacterium tuberculosis in sputa of two health centers in Iran. | 2017 | 3 |
| 17 | 2021 | 2 | |
| 18 | 2022 | 2 | |
| 19 | 2018 | 2 | |
| 20 | Genomic Characterization and Phylogenetic Analysis of SARS-CoV-2 during the early phase of the pandemic in Asia | 2021 | 1 |
About Jale Moradi
Jale Moradi is a scholar working on Infectious Diseases, Molecular Biology, Molecular Medicine, Surgery and Epidemiology, having authored 20 papers that have together received 297 indexed citations. Recurring topics across this work include vaccines and immunoinformatics approaches (6 papers), Antibiotic Resistance in Bacteria (5 papers), Tuberculosis Research and Epidemiology (4 papers), Gut microbiota and health (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Mycobacterium research and diagnosis (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Molecular Medicine (146 citations), Applied Microbiology and Biotechnology (21 citations), Endocrinology (52 citations), Pollution (59 citations) and Infectious Diseases (76 citations). Jale Moradi has collaborated with scholars based in Iran, Germany and United Kingdom. Frequent co-authors include Farhad B. Hashemi, Abbas Bahador, Ramin Abiri, Esmaeil Babaei, Mohammad M. Feizabadi, Mehri Haeili, Hamid Motamedi, Marzie Mahdizade Ari, Shirin Dashtbin and Amirhooshang Alvandi. Their work appears in journals such as Osong Public Health and Research Perspectives, Scientific Reports, BMC Bioinformatics, Sensing and Bio-Sensing Research and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.